FINWIRES · TerminalLIVE
FINWIRES

Aarti Pharmalabs' Fiscal Q4 Consolidated Profit Slumps

By

Aarti Pharmalabs (NSE:AARTIPHARM, BOM:543748) reported a decline in its attributable consolidated profit to 611.2 million Indian rupees in the fiscal fourth quarter ended March 31 from 883.4 million rupees a year earlier, according to a Tuesday filing on the Indian bourses.

Earnings per share contracted to 6.74 rupees from 9.74 rupees in the same quarter last year.

Net revenue from operations rose to 5.83 billion rupees from 5.64 billion rupees a year ago.

The company recommended a final dividend of 2 rupees per share for the fiscal year ended March 31.

Related Articles

Asia

Venus Pipes & Tubes' Fiscal Q4 Profit Rises

Venus Pipes & Tubes Ltd (BOM:543528, NSE:VENUSPIPES) reported an increase in net profit to 255 million Indian rupees in the fiscal fourth quarter ended March 31 from 237.1 million rupees a year earlier, according to a Tuesday filing on the Indian bourses.Earnings per share climbed to 12.36 rupees from 11.60 rupees in the same quarter last year.Revenue from operations rose to 3.02 billion rupees from 2.58 billion rupees a year ago.The company recommended a final dividend of 0.50 rupees per share for the fiscal year ended March 31.

$BOM:543528$NSE:VENUSPIPES
Asia

Honz Pharmaceutical Gets Clinical Trial Approval for Pediatric Indication for Antibiotic

China's drug regulator approved Honz Pharmaceutical's (SHE:300086) clinical trial for a pediatric indication for its Ceftazidime Tazobactam Sodium injection, according to a Tuesday filing with the Shenzhen bourse.The drug treats moderate to severe infections caused by beta-lactamase-producing bacteria.

$SHE:300086
Asia

Jahen Household Products to Seek 980-Million-Yuan Credit Line

Jahen Household Products (SHE:300955) and its subsidiaries will seek a 980 million yuan comprehensive credit line, according to a Tuesday filing with the Shenzhen bourse.The manufacturer of chemical products and plastic containers will provide a guarantee of 830 million yuan for its wholly owned subsidiaries.

$SHE:300955